Case Study: Securing Long-Term, Cost-Effective Supply of Eylea EU & USA for programs of studies

Request

A global listed Biotech company required large quantities of Eylea Pre-Filled Syringes (PFS) sourced across both the EU and USA. Their priorities included:

• Relatively Stable pricing over a 2-3 year period

  
  

• Best possible expiry dates to accommodate packaging timelines (losing 6-8 weeks in the process)

  
  

• Ensuring continuous supply by replenishing stock before expiry (~14-16 months)

  
  

• Bulk procurement in single large batches for efficiency in regular intervals

Challenges

• Maintaining Cost Stability – The client needed price consistency despite market fluctuations over multiple years.

  
  

• Expiry Date Optimization – Ensuring the longest possible shelf life to offset packaging delays.

  
  

• Uninterrupted Supply Chain – Stock replenishment had to be seamless, avoiding disruptions and putting patients at risk

  
  

• Large-Scale Procurement – Sourcing high volumes in one batch while maintaining quality and compliance.

  
  

CSI’s Solution

• Strategic Bulk Sourcing: CSI successfully procured thousands of units in USA and Europe in very large batches, securing availability and reducing procurement cycles.

  
  

• Pricing Stability Over 3 Years: Thanks to strong, long-term relationships with strategic partners, CSI maintained consistent pricing despite market shifts.

  
  

• Direct Procurement from Manufacturer: By sourcing, CSI ensured a short, secure, and reliable supply chain with minimal risk.

Results & Impact

• Reliable, uninterrupted supply for the client's clinical trial needs

  
  

• Optimized expiry dates to maximize product usability post-packaging

  
  

• Cost-effective procurement, reducing financial uncertainty

At CSI, we deliver strategic, secure and cost-effective clinical supply solutions—ensuring trial success through efficient sourcing and supply chain expertise.